Trial Profile
Molecular Mechanisms of Endothelial Dysfunction in Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Meglitinide; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 30 May 2012 Actual initiation date (Mar 2007), trial company, lead trial centres and investigator a added as reported by ClinicalTrials.gov.
- 30 May 2012 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 30 May 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT00816218).